Closing the gender pay gap is good for women and, of course, for employers and our economy. That is why we are requiring large employers to publish their pay gap data. Occupational segregation is one of the main causes of the pay gap, which is why we have announced the ambition of a 20% increase in girls taking A-level maths and science by 2020.

What support his Department is providing to children who need sports prostheses.

My hon. Friend is absolutely right that jobs in science, technology, engineering and mathematics carry a significant wage premium. Although women make up 50% of STEM undergraduates, that simply does not translate into the workplace. That is why we have set up a new careers and enterprise company to bring schools and businesses together to inspire and inform young people. We have also published guidance called “Your Daughter’s Future” to help parents to guide their daughters in subject and career choices.

I thank the Minister for that answer. A continuing cause of the pay gap is the lower incidence of women studying science and engineering at university. Does she agree that closing the STEM gap is a prerequisite for closing the pay gap?

The hon. Lady is absolutely right. That is why this Government have done more than any before to extend the right to flexible working to all employees. We will continue to work with businesses to encourage them to get the very best out of every single one of their staff.

The Women and Equalities Committee’s report on the gender pay gap showed strong and compelling evidence that increasing the availability of well-paid flexible work would make a significant difference in reducing the pay gap. What will the Government do to make flexible working easy and to encourage employers to offer it from the date of employment rather than having to wait for six months?

The answer is not to change the names of the men, as someone has suggested.

The private sector has made great progress in gender equality in recent years, but there is still a big problem. Research by Simon Fanshawe has proved that there are more men called Andrew, David and John in senior positions in FTSE 100 companies than there are women. What more can the Government do to incentivise good practice and better gender equality in the FTSE 100? [Interruption.]

The private sector has made great progress in gender equality in recent years, but there is still a big problem. Research by Simon Fanshawe has proved that there are more men called Andrew, David and John in senior positions in FTSE 100 companies than there are women. What more can the Government do to incentivise good practice and better gender equality in the FTSE 100? [Interruption.]

NHS England has not refused to fund micro-processor knees. A revised policy proposal for the routine commissioning of microprocessor controlled knees was considered by NHS England’s expert Clinical Priorities Advisory Group which recommended its adoption for routine commissioning. The proposal was then considered by NHS England’s Specialised Commissioning Oversight Group at its meeting on 9 December 2015 where it was agreed that NHS England would support this service development as a possible call on its resources. However given the potential scale of investment and the need to consider its priority relative to other treatments which would also have a possible call on the specialised commissioning resources it was decided that the policy should go forward for consideration as part of NHS England's next annual prioritisation round in June 2016.

NHS England has not refused to fund micro-processor knees. A revised policy proposal for the routine commissioning of microprocessor controlled knees was considered by NHS England’s expert Clinical Priorities Advisory Group which recommended its adoption for routine commissioning. The proposal was then considered by NHS England’s Specialised Commissioning Oversight Group at its meeting on 9 December 2015 where it was agreed that NHS England would support this service development as a possible call on its resources. However given the potential scale of investment and the need to consider its priority relative to other treatments which would also have a possible call on the specialised commissioning resources it was decided that the policy should go forward for consideration as part of NHS England's next annual prioritisation round in June 2016.

Work is currently under way between the Ministry of Defence, NHS England and the UK Departments of Health to put in place a patient referral pathway to enable access for eligible military personnel and Veterans to the Direct Skeletal Fixation programme. This includes the definition of clinical criteria to access the programme as the procedure will not be appropriate for every individual. The programme is expected to begin in spring 2016 for two and a half years and the results will be published following completion.

The commissioning of prosthetics is the responsibility of NHS England as a specialised service. The rehabilitation and re-ablement of patients is provided at a local level by specialised Multi-Disciplinary Teams which should be consultant led. The NHS Standard Contract for Complex Disability Equipment – Prosthetics, sets out how the specialist centres should operate and the required level of prosthetic services to be delivered.

A revised policy proposal for the routine commissioning of microprocessor controlled knees was considered by NHS England’s expert Clinical Priorities Advisory Group which recommended its adoption for routine commissioning. The proposal was then considered by NHS England’s Specialised Commissioning Oversight Group at its meeting on 9 December where it was agreed that NHS England would support this service development as a possible call on its resources. However given the potential scale of investment and the need to consider its priority relative to other treatments which would also have a possible call on the specialised commissioning resources, it was decided that the policy should go forward for consideration as part of NHS England's next annual prioritisation round in June 2016.

The commissioning of prosthetics is the responsibility of NHS England as a specialised service. The rehabilitation and re-ablement of patients is provided at a local level by specialised Multi-Disciplinary Teams which should be consultant led. The NHS Standard Contract for Complex Disability Equipment – Prosthetics, sets out how the specialist centres should operate and the required level of prosthetic services to be delivered.

A revised policy proposal for the routine commissioning of microprocessor controlled knees was considered by NHS England’s expert Clinical Priorities Advisory Group which recommended its adoption for routine commissioning. The proposal was then considered by NHS England’s Specialised Commissioning Oversight Group at its meeting on 9 December where it was agreed that NHS England would support this service development as a possible call on its resources. However given the potential scale of investment and the need to consider its priority relative to other treatments which would also have a possible call on the specialised commissioning resources, it was decided that the policy should go forward for consideration as part of NHS England's next annual prioritisation round in June 2016.

The commissioning of prosthetics is the responsibility of NHS England as a specialised service. The rehabilitation and re-ablement of patients is provided at a local level by specialised Multi-Disciplinary Teams which should be consultant led. The NHS Standard Contract for Complex Disability Equipment – Prosthetics, sets out how the specialist centres should operate and the required level of prosthetic services to be delivered.

A revised policy proposal for the routine commissioning of microprocessor controlled knees was considered by NHS England’s expert Clinical Priorities Advisory Group which recommended its adoption for routine commissioning. The proposal was then considered by NHS England’s Specialised Commissioning Oversight Group at its meeting on 9 December where it was agreed that NHS England would support this service development as a possible call on its resources. However given the potential scale of investment and the need to consider its priority relative to other treatments which would also have a possible call on the specialised commissioning resources, it was decided that the policy should go forward for consideration as part of NHS England's next annual prioritisation round in June 2016.

NHS England has advised that it has commissioned an independent evidence review in relation to microprocessor knees, multi-articulating prosthetic hands and custom made silicon covers which is expected to be complete by September 2015. A more detailed understanding of next steps including potential timelines will be possible once the evidence review has been considered by NHS England.

DFID does not routinely carry out such assessments. Following the conflict in Gaza, DFID provided £724,518 to a Medical Aid for Palestinians (MAP) project which provided support for trauma and plastic reconstructive surgery and essential medical equipment to Gaza hospitals.

MAP published a report on a mission carried out in August 2014 to make an assessment of needs and any immediate surgical work if required which can be read here: http://www.map-uk.org/downloads/map-ideals-gaza-medical-report-august-2014-(2).pdf.

NHS England has informed us that it has established a Prosthetics subgroup which reports to the Complex Disability Equipment Clinical Reference Group. This sub-group consists of patients, their representatives, clinicians and representatives from the professional bodies and the prosthetics industry. This sub-group has focussed on various aspects relating to the service model which are reflected in the revised Prosthetics Service specification published on the NHS England website earlier this year.

The subgroup have also developed draft clinical commissioning policies for microprocessor prosthetic knees and multi grip upper arm prostheses but recognise the need to undertake more work on strengthening the clinical evidence and the links with potential to benefit. The further work required to strengthen the evidence for the draft policies should be complete by the autumn of this year.

These draft policies can be found at:

http://www.england.nhs.uk/commissioning/spec-services/npc-crg/group-d/d01/